First potential curative treatment for CVI advances into a pivotal Phase II/III trial - Pivotal Phase II/III clinical trial underway, aiming for US and European market approval in 2028 - A 'truly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results